{"id":"https://openalex.org/W118369248","doi":null,"title":"Patient management strategies for interferon alfa-2b as adjuvant therapy of high-risk melanoma.","display_name":"Patient management strategies for interferon alfa-2b as adjuvant therapy of high-risk melanoma.","publication_year":1998,"publication_date":"1998-06-01","ids":{"openalex":"https://openalex.org/W118369248","mag":"118369248","pmid":"https://pubmed.ncbi.nlm.nih.gov/9644709"},"language":"en","primary_location":{"id":"pmid:9644709","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9644709","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology nursing forum","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021240993","display_name":"Sandra Donnelly","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"S Donnelly","raw_affiliation_strings":["Clinical Research Services, University of Pittsburgh Cancer Center, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Services, University of Pittsburgh Cancer Center, PA, USA","institution_ids":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5021240993"],"corresponding_institution_ids":["https://openalex.org/I170201317","https://openalex.org/I4210128526"],"apc_list":null,"apc_paid":null,"fwci":0.5552,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":{"value":0.66559486,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"25","issue":"5","first_page":"921","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interferon-alpha-2b","display_name":"interferon alfa-2b","score":0.9980000257492065},{"id":"https://openalex.org/keywords/high-risk-melanoma","display_name":"high-risk melanoma","score":0.8809999823570251},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.9929999709129333},{"id":"https://openalex.org/keywords/oncology-nursing","display_name":"oncology nursing","score":0.7739999890327454},{"id":"https://openalex.org/keywords/clinical-management","display_name":"clinical management","score":0.7070000171661377},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.6729999780654907},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.7739999890327454},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.628000020980835},{"id":"https://openalex.org/keywords/relapse-free-survival","display_name":"relapse-free survival","score":0.9729999899864197},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9620000123977661}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9562454223632812},{"id":"https://openalex.org/C2777982462","wikidata":"https://www.wikidata.org/wiki/Q2481887","display_name":"Adjuvant therapy","level":3,"score":0.6887479424476624},{"id":"https://openalex.org/C27415008","wikidata":"https://www.wikidata.org/wiki/Q7256382","display_name":"Psychological intervention","level":2,"score":0.6138009428977966},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.6133498549461365},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.6041697263717651},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.5991771221160889},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5045324563980103},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.47213679552078247},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47182899713516235},{"id":"https://openalex.org/C2909179924","wikidata":"https://www.wikidata.org/wiki/Q6046488","display_name":"Alpha interferon","level":3,"score":0.4711638391017914},{"id":"https://openalex.org/C140117577","wikidata":"https://www.wikidata.org/wiki/Q260842","display_name":"Nursing Interventions Classification","level":3,"score":0.46044716238975525},{"id":"https://openalex.org/C2781228144","wikidata":"https://www.wikidata.org/wiki/Q6046441","display_name":"Interferon alfa","level":4,"score":0.4580802321434021},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.37433338165283203},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.29512181878089905},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2403348684310913},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.23191174864768982},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.17152610421180725},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1042751669883728},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000077190","descriptor_name":"Interferon alpha-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000451","qualifier_name":"nursing","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009730","descriptor_name":"Nursing Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010353","descriptor_name":"Patient Education as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017024","descriptor_name":"Chemotherapy, Adjuvant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:9644709","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9644709","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology nursing forum","raw_type":"Journal Article"},{"id":"mag:118369248","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9644709","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2410818381","https://openalex.org/W1988830219","https://openalex.org/W1828940258","https://openalex.org/W1537788830","https://openalex.org/W2035490260","https://openalex.org/W7095503047","https://openalex.org/W2090000910","https://openalex.org/W2002265007","https://openalex.org/W96088601","https://openalex.org/W2147157854"],"abstract_inverted_index":{"PURPOSE/OBJECTIVES:":[0],"To":[1],"review":[2],"results":[3,32,59],"of":[4,15,33,47,101,111],"Eastern":[5],"Cooperative":[6],"Oncology":[7],"Group":[8],"(ECOG)":[9],"trial":[10,35,44],"E1684":[11,36],"in":[12,125],"the":[13,43],"context":[14],"nursing":[16,91,131,144],"issues":[17],"concerning":[18],"interferon":[19],"alfa-2b":[20],"(IFN":[21],"alpha-2b)":[22],"as":[23],"adjuvant":[24,156],"therapy":[25],"for":[26],"high-risk":[27,128],"melanoma.":[28],"DATA":[29,68],"SOURCES:":[30],"Published":[31],"ECOG":[34],"and":[37,60,80,122,146],"additional":[38],"safety":[39,58],"data":[40],"provided":[41],"by":[42],"sponsor.":[45],"Selection":[46],"material":[48],"was":[49],"based":[50],"on":[51,56],"information":[52],"that":[53],"would":[54],"expand":[55],"published":[57],"present":[61],"patient-management":[62],"strategies":[63],"relevant":[64],"to":[65,135],"oncology":[66],"nurses.":[67],"SYNTHESIS:":[69],"High-dose":[70],"IFN":[71,116],"alpha-2b":[72,117],"significantly":[73,119],"prolonged":[74],"median":[75],"relapse-free":[76,121],"survival":[77,82,124],"(<":[78],"0.01)":[79],"overall":[81,123],"(p":[83],"=":[84],"0.047),":[85],"but":[86,130],"side":[87],"effects":[88],"required":[89,134],"extensive":[90],"interventions.":[92],"With":[93],"appropriate":[94,147],"patient":[95,137],"management,":[96],"including":[97],"dose":[98],"modifications,":[99],"74%":[100],"patients":[102,126,151],"who":[103],"did":[104],"not":[105],"relapse":[106],"received":[107],"a":[108],"full":[109],"course":[110],"therapy.":[112,157],"CONCLUSIONS:":[113],"Adjuvant,":[114],"high-dose":[115],"can":[118,149],"prolong":[120],"with":[127],"melanoma,":[129],"interventions":[132,148],"are":[133],"ensure":[136],"compliance.":[138],"IMPLICATIONS":[139],"FOR":[140],"NURSING":[141],"PRACTICE:":[142],"Accurate":[143],"assessment":[145],"help":[150],"safely":[152],"complete":[153],"this":[154],"effective":[155]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}